David P Schenkein Denali Therapeutics Inc. (DNLI) insider trading activity
David P Schenkein is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 15,257 shares of DNLI, which is worth approximately $211,004. The most recent transaction as insider was on Jun 03, 2025, when has been sold 6,037 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
15.3K
65.48%
3M change
29.02%
12M change
Total Value Held
$211,004
David P Schenkein Transaction History
Also insider at
DPS
David P Schenkein
Director
South San Francisco, CA